Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 335

2.

Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure.

St John Sutton MG, Plappert T, Abraham WT, Smith AL, DeLurgio DB, Leon AR, Loh E, Kocovic DZ, Fisher WG, Ellestad M, Messenger J, Kruger K, Hilpisch KE, Hill MR; Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study Group.

Circulation. 2003 Apr 22;107(15):1985-90. Epub 2003 Mar 31.

3.

Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I/II heart failure.

St John Sutton M, Ghio S, Plappert T, Tavazzi L, Scelsi L, Daubert C, Abraham WT, Gold MR, Hassager C, Herre JM, Linde C; REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) Study Group.

Circulation. 2009 Nov 10;120(19):1858-65. doi: 10.1161/CIRCULATIONAHA.108.818724. Epub 2009 Oct 26.

4.

The ischemic etiology of heart failure in diabetics limits reverse left ventricular remodeling after cardiac resynchronization therapy.

Soliman OI, van Dalen BM, Theuns DA, ten Cate FJ, Nemes A, Jordaens LJ, Geleijnse ML.

J Diabetes Complications. 2009 Sep-Oct;23(5):365-70. doi: 10.1016/j.jdiacomp.2008.04.003. Epub 2008 Jun 24.

PMID:
18572420
5.

Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.

Daubert C, Gold MR, Abraham WT, Ghio S, Hassager C, Goode G, Szili-Török T, Linde C; REVERSE Study Group.

J Am Coll Cardiol. 2009 Nov 10;54(20):1837-46. doi: 10.1016/j.jacc.2009.08.011. Epub 2009 Oct 1.

6.

Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.

Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C; REVERSE (REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction) Study Group.

J Am Coll Cardiol. 2008 Dec 2;52(23):1834-43. doi: 10.1016/j.jacc.2008.08.027. Epub 2008 Nov 7.

7.

Reverse of left ventricular volumetric and structural remodeling in heart failure patients treated with cardiac resynchronization therapy.

Soliman OI, Geleijnse ML, Theuns DA, Nemes A, Vletter WB, van Dalen BM, Motawea AK, Jordaens LJ, ten Cate FJ.

Am J Cardiol. 2008 Mar 1;101(5):651-7. doi: 10.1016/j.amjcard.2007.10.027. Epub 2008 Feb 21.

PMID:
18308015
8.

Ventricular reverse remodeling and 6-month outcomes in patients receiving cardiac resynchronization therapy: analysis of the MIRACLE study.

Woo GW, Petersen-Stejskal S, Johnson JW, Conti JB, Aranda JA Jr, Curtis AB.

J Interv Card Electrophysiol. 2005 Mar;12(2):107-13.

PMID:
15744462
9.
10.

Predictive parameters of left ventricular reverse remodeling in response to cardiac resynchronization therapy in patients with severe congestive heart failure.

De Maria E, Gallo P, Damiano M, Scognamiglio G, De Simone C, Nilo S, Guarini P, Mascioli G, Curnis A.

Ital Heart J. 2005 Sep;6(9):734-9.

PMID:
16212075
11.

Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.

Bleeker GB, Schalij MJ, Holman ER, Steendijk P, van der Wall EE, Bax JJ.

Am J Cardiol. 2006 Jul 15;98(2):230-5. Epub 2006 May 19.

PMID:
16828599
12.

Left ventricular dyssynchrony predicts right ventricular remodeling after cardiac resynchronization therapy.

Bleeker GB, Schalij MJ, Nihoyannopoulos P, Steendijk P, Molhoek SG, van Erven L, Bootsma M, Holman ER, van der Wall EE, Bax JJ.

J Am Coll Cardiol. 2005 Dec 20;46(12):2264-9.

13.

Value of baseline left lateral wall postsystolic displacement assessed by M-mode to predict reverse remodeling by cardiac resynchronization therapy.

Sassone B, Capecchi A, Boggian G, Gabrieli L, Saccà S, Vandelli R, Petracci E, Mele D.

Am J Cardiol. 2007 Aug 1;100(3):470-5. Epub 2007 Jun 15.

PMID:
17659931
14.

Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography.

Yu CM, Chan YS, Zhang Q, Yip GW, Chan CK, Kum LC, Wu L, Lee AP, Lam YY, Fung JW.

J Am Coll Cardiol. 2006 Dec 5;48(11):2251-7.

15.

Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.

Bonanno C, Ometto R, Pasinato S, Finocchi G, La Vecchia L, Fontanelli A.

Ital Heart J. 2004 May;5(5):364-70.

PMID:
15185900
16.

Comparison of efficacy of reverse remodeling and clinical improvement for relatively narrow and wide QRS complexes after cardiac resynchronization therapy for heart failure.

Yu CM, Fung JW, Chan CK, Chan YS, Zhang Q, Lin H, Yip GW, Kum LC, Kong SL, Zhang Y, Sanderson JE.

J Cardiovasc Electrophysiol. 2004 Sep;15(9):1058-65.

PMID:
15363081
18.

Early and late effects of cardiac resynchronization therapy on exercise-induced mitral regurgitation: relationship with left ventricular dyssynchrony, remodelling and cardiopulmonary performance.

Madaric J, Vanderheyden M, Van Laethem C, Verhamme K, Feys A, Goethals M, Verstreken S, Geelen P, Penicka M, De Bruyne B, Bartunek J.

Eur Heart J. 2007 Sep;28(17):2134-41. Epub 2007 May 15.

20.

Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.

Abraham WT, Young JB, León AR, Adler S, Bank AJ, Hall SA, Lieberman R, Liem LB, O'Connell JB, Schroeder JS, Wheelan KR; Multicenter InSync ICD II Study Group.

Circulation. 2004 Nov 2;110(18):2864-8. Epub 2004 Oct 25.

Items per page

Supplemental Content

Write to the Help Desk